VF

Virtu Financial Portfolio holdings

AUM $1.79B
1-Year Est. Return 33.6%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+33.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.79B
AUM Growth
-$166M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,327
New
Increased
Reduced
Closed

Top Buys

1
+$83.7M
2
+$38.6M
3
+$22.9M
4
SMR icon
NuScale Power
SMR
+$20.9M
5
LLYVA icon
Liberty Live Group Series A
LLYVA
+$19.2M

Top Sells

1
+$266M
2
+$150M
3
+$84.7M
4
RDFN
Redfin
RDFN
+$34.6M
5
AAPL icon
Apple
AAPL
+$21.6M

Sector Composition

1 Financials 22.21%
2 Technology 13.17%
3 Communication Services 11.71%
4 Healthcare 8.65%
5 Industrials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUUN
1451
PowerBank Corp
SUUN
$66.4M
– –
-50,504
HAFN icon
1452
Hafnia
HAFN
$3.11B
– –
-96,204
ULS icon
1453
UL Solutions
ULS
$14.4B
– –
-4,038
TWG
1454
Top Wealth Group Holding Ltd
TWG
$5.31M
– –
-853
IBTA icon
1455
Ibotta
IBTA
$546M
– –
-5,919
MRX
1456
Marex Group
MRX
$2.9B
– –
-7,387
SVCO
1457
Silvaco Group
SVCO
$119M
– –
-14,040
BIOA
1458
BioAge Labs
BIOA
$866M
– –
-14,911
CNR
1459
Core Natural Resources Inc
CNR
$4.73B
– –
-3,262
CUB
1460
Lionheart Holdings
CUB
$328M
– –
-57,636
TLN
1461
Talen Energy Corp
TLN
$15.8B
– –
-9,147
CNH
1462
CNH Industrial
CNH
$15.4B
– –
-18,379
ETHU
1463
2x Ether ETF
ETHU
$817M
– –
-171,293
ATYR
1464
aTyr Pharma
ATYR
$88.1M
– –
-31,959
QXO
1465
QXO Inc
QXO
$16.5B
– –
-43,959
CGGE
1466
Capital Group Global Equity ETF
CGGE
$2.01B
– –
-31,893
GPAT
1467
GP-Act III Acquisition Corp
GPAT
$386M
– –
-58,731
FSUN
1468
FirstSun Capital Bancorp
FSUN
$1.12B
– –
-5,914
MACI
1469
Melar Acquisition Corp I
MACI
$231M
– –
-85,918
BLMZ
1470
DELISTED
Harrison Global Holdings
BLMZ
– –
-3,103
LTM
1471
LATAM Airlines Group S.A.
LTM
$18.6B
– –
-20,985
BGM
1472
BGM Group Ltd
BGM
$229M
– –
-13,553
CEP
1473
DELISTED
Cantor Equity Partners
CEP
– –
-38,864
QNTM
1474
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$16.1M
– –
-16,706
SLXN
1475
Silexion Therapeutics
SLXN
$5.47M
– –
-951
57 58
59
60 61